BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Egalet Announces ARYMO ER Added to Large Payer Medicare Part D Formulary

  Egalet today announced that a large payer will provide coverage of ARYMO ER (morphine sulfate) extended-release tablets for oral use -CII for its Medicare Part D members.

  November 6, 2017

   · 

  17 min read
• Biotech Beach

  ChemDiv’s Discovery Chemistry Platform to Help Advance Tri-Institutional Therapeutics Discovery Institute Programs ChemDiv logo

  This collaboration with ChemDiv is aimed at assisting Tri-I TDI investigators with developing therapies across multiple therapeutic areas.

  November 6, 2017

   · 

  1 min read
• Business

  Catalent Reports First Quarter Fiscal 2018 Results

  First quarter 2018 revenue of $543.9 million increased 23% as reported and 22% in constant currency from $442.2 million reported in the first quarter a year ago.

  November 6, 2017

   · 

  26 min read
• Drug Development

  Lupus Research Alliance Prompted Stelara Study for Lupus - Results Show Potential for New Treatment Option

  Based on the positive results from the Phase II study, Janssen announced plans to test Stelara in a future Phase III program.

  November 6, 2017

   · 

  3 min read
• 

  Policy

  Achillion’s ACH-4471 is an Orphan Drug in the U.S. and Europe for PNH

  The EMA Committee for Orphan Medicinal Products also issued a positive opinion on ACH-4471 for orphan status in the European Union for the treatment of PNH.

  November 6, 2017

   · 

  7 min read
• Business

  Adaptive Biotechnologies Announces a Collaboration with Amgen to Advance Clinical Development of the clonoSEQ Assay in Multiple Myeloma

  Adaptive Biotechnologies announces it has entered into a collaboration agreement with Amgen to utilize Adaptive’s NGS-based clonoSEQ Assay in the Phase 3 CANDOR study.

  November 6, 2017

   · 

  2 min read
• Biohit Oyj B-shares Subscribed With Stock Options I 2013

  A total number of 110 000 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 5 May 2017 and 12 October 2017.

  November 6, 2017

   · 

  1 min read
• Biotech Beach

  Ensysce Biosciences to Present at Human Abuse Liability & Abuse-Deterrent Formulations Conference in Bethesda, Maryland on November 6th and 7th

  The conference will provide information and training to participants on topics such as: preclinical development of abuse-deterrent drugs and delivery mechanisms, clinical trial design, and building strong, reliable networks with every stakeholder throughout the regulatory and market access community.

  November 6, 2017

   · 

  3 min read
• Tigenix Announces Partial Conversion of Bonds

  Through this conversion, the total convertible debt outstanding is reduced from EUR 25 million to EUR 18 million.

  November 6, 2017

   · 

  3 min read
• Biotech Beach

  Glutenostics Launches Gluten Detective, the First at-Home Gluten Consumption Monitoring Test

  In just 15 minutes or more, in the privacy of a bathroom anywhere in the world, people are now able to sample their urine or stool to detect gluten fragments indicative of gluten consumption over the previous 1-2 or more days.

  November 6, 2017

   · 

  2 min read